Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders
VetReach
Using Telehealth to Expand Treatment Access for Veterans With Opioid Use Disorder (CDA 18-008)
2 other identifiers
interventional
25
1 country
1
Brief Summary
This project will pilot-test and obtain stakeholder input on a telehealth-delivered substance use disorder (SUD) care model (with initial engagement and ongoing MI-CBT treatment) with the goal of increasing treatment utilization and improving outcomes for rural and non-rural Veterans with SUDs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 21, 2022
CompletedFirst Posted
Study publicly available on registry
April 27, 2022
CompletedStudy Start
First participant enrolled
May 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
August 14, 2025
August 1, 2025
4.4 years
April 21, 2022
August 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility of the intervention (engagement)
Percent (%) of participants engaging in the intervention (at least 3 completed sessions)
8 weeks
Acceptability of the telehealth intervention
Study-specific acceptability rating completed by participants (% with a positive rating, higher % is better)
2 months
Other Outcomes (2)
Change in substance consumption
baseline, 8 weeks post-baseline
Change in frequency of substance use as reported on the Timeline Follow-Back (TLFB)
baseline, 8 weeks post-baseline
Study Arms (1)
MI-CBT Teletx
EXPERIMENTALThe intervention consists of an initial 30-60 min phone-delivered Engagement session that focuses on MI to help participants build self-efficacy and motivation to engage and to empower them to plan change and use Elicit-Provide-Elicit (EPE) to address treatment barriers (e.g., stigma, appeal, accessibility). Participants will then complete up to 8 \~50 minute Teletx weekly sessions via videoconference (or phone if needed). The intervention is highly patient-centered, by meeting and assessing patients where they are including in their unique context (i.e. rural community), helping them identify reasons and motivations for change, and centered around their goals (e.g. substance use reduction or abstinence).
Interventions
Eligibility Criteria
You may qualify if:
- Veteran patients at the Ann Arbor VA Healthcare System
- Diagnostic and Statistical Manual of Mental Disorders (DSM-5) SUD diagnosis and/or substance use on average of 2 days a week over the past month
- Telephone access
- Able to provide informed consent
You may not qualify if:
- Receiving SUD psychotherapy
- Inability to speak or understand English
- Substantial mental health instability or conditions that preclude informed consent (e.g., acute psychosis, cognitive deficits) or understanding of assessment or program content
- Prior alcohol withdrawal seizures or delirium tremens
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Ann Arbor Healthcare System, Ann Arbor, MI
Ann Arbor, Michigan, 48105-2303, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lewei Lin, MD
VA Ann Arbor Healthcare System, Ann Arbor, MI
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2022
First Posted
April 27, 2022
Study Start
May 19, 2022
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
September 30, 2026
Last Updated
August 14, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share